Commentary

When benefits are considered through the lenses of human needs and life stages, organizations can more easily identify gaps and opportunities they may not otherwise recognize.

For employers' health plans, the new ATTR-CM specialty drugs could cost $500,000 per participant treated.

A stop-loss market veteran looks at the differences between the two types of ERISA self-funded plans.

It's a critical time for employees who are trying to make the best financial decisions for themselves and their families, with the pressures of health care costs, and financial planning for the new year all amplifying that stress.

Fixing messy data after it arrives is a trap.

Decision support tools have helped, and now there's more focus on how AI-driven recommendation capabilities can build on that.